Human Urine-derived Stem Cells Seeded Surface Modified Composite Scaffold Grafts for Bladder Reconstruction in a Rat Model

다국어 초록 (Multilingual Abstract)

We conducted this study to investigate the synergistic effect of human urine-derived stem cells (USCs) and surface modified composite scaffold for bladder reconstruction in a rat model. The composite scaffold (Polycaprolactone/Pluronic F127/3 wt% bladder submucosa matrix) was fabricated using an immersion precipitation method, and heparin was immobilized on the surface via covalent conjugation. Basic fibroblast growth factor (bFGF) was loaded onto the heparin-immobilized scaffold by a simple dipping method. In maximal bladder capacity and compliance analysis at 8 weeks post operation, the USCsscaffoldheparin- bFGF group showed significant functional improvement (2.34 ± 0.25 mL and 55.09 ± 11.81 μL/cm H2O) compared to the other groups (2.60 ± 0.23 mL and 56.14 ± 9.00 μL/cm H2O for the control group, 1.46 ± 0.18 mL and 34.27 ± 4.42 μL/cm H2O for the partial cystectomy group, 1.76 ± 0.22 mL and 35.62 ± 6.69 μL/cm H2O for the scaffold group, and 1.92 ± 0.29 mL and 40.74 ± 7.88 μL/cm H2O for the scaffoldheparin-bFGF group, respectively). In histological and immunohistochemical analysis, the USC-scaffoldheparin-bFGF group showed pronounced, well-differentiated, and organized smooth muscle bundle formation, a multi-layered and pan-cytokeratin-positive urothelium, and high condensation of submucosal area. The USCs seeded scaffoldheparin-bFGF exhibits significantly increased bladder capacity, compliance, regeneration of smooth muscle tissue, multi-layered urothelium, and condensed submucosa layers at the in vivo study.

참고문헌 (Reference)

1 Zhang Y, "Urine derived cells are a potential source for urological tissue reconstruction" 180 : 2226-2233, 2008

2 Lech M, "Tissues use resident dendritic cells and macrophages to maintain homeostasis and to regain homeostasis upon tissue injury : the immunoregulatory role of changing tissue environments" 2012 : 951390-, 2012

3 Atala A, "Tissue engineering of human bladder" 97 : 81-104, 2011

4 Jednak R, "The evolution of bladder augmentation : from creating a reservoir to reconstituting an organ" 2 : 10-, 2014

5 Geng HQ, "The bladder submucosa acellular matrix as a cell deliverer in tissue engineering" 2 : 57-60, 2006

6 Lanza RP, "Principles of tissue engineering" Academic Press 2013

7 Salem SA, "Polylactic-co-glycolic acid mesh coated with fibrin or collagen and biological adhesive substance as a prefabricated, degradable, biocompatible, and functional scaffold for regeneration of the urinary bladder wall" 101 : 2237-2247, 2013

8 Sasisekharan R, "On the regulation of fibroblast growth factor activity by heparin-like glycosaminoglycans" 1 : 45-54, 1997

9 Steffens GC, "Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor" 10 : 1502-1509, 2004

10 Jeon O, "Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide)nanospheres and fibrin gel" 27 : 1598-1607, 2006

11 Jonnalagadda SB, "Kinetics of reduction of toluidine blue with sulfite-kinetic salt effect in elucidation of mechanism" 77 : 506-, 2000

12 Pigott JH, "Investigation of the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses" 156 : 99-106, 2013

13 Lee M, "Intestinal smooth muscle cell maintenance by basic fibroblast growth factor" 14 : 1395-1402, 2008

14 Cai S, "Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor" 26 : 6054-6067, 2005

15 Liu LS, "Hyaluronate-heparin conjugate gels for the delivery of basic fibroblast growth factor(FGF-2)" 62 : 128-135, 2002

16 Kim BS, "Human amniotic fluid stem cell injection therapy for urethral sphincter regeneration in an animal model" 10 : 94-, 2012

17 Zambon JP, "Histological changes induced by Polyglycolic-Acid(PGA)scaffolds seeded with autologous adipose or muscle-derived stem cells when implanted on rabbit bladder" 10 : 278-288, 2014

18 Yoon JJ, "Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor" 79 : 934-942, 2006

19 Kim BS, "Engineering smooth muscle tissue with a predefined structure" 41 : 322-332, 1998

20 Oh SH, "Effect of surface pore structure of nerve guide conduit on peripheral nerve regeneration" 19 : 233-243, 2013

21 Wang XH, "Covalent immobilization of chitosan and heparin on PLGA surface" 33 : 95-100, 2003

22 Lee AC, "Controlled release of nerve growth factor enhances sciatic nerve regeneration" 184 : 295-303, 2003

23 Smith PK, "Colorimetric method for the assay of heparin content in immobilized heparin preparations" 109 : 466-473, 1980

24 Chun SY, "Characterization of urine-derived cells from upper urinary tract in patients with bladder cancer" 79 : 1186.e1-1181.e7, 2012

25 Jang YJ, "Characterization of a novel composite scaffold consisting of acellular bladder submucosa matrix, polycaprolactone and Pluronic F127 as a substance for bladder reconstruction" 10 : 3117-3125, 2014

26 Yu DS, "Bladder wall grafting in rats using salt-modified and collagen-coated polycaprolactone scaffolds : preliminary report" 14 : 939-944, 2007

27 Zhang Y, "Bladder regeneration with cell-seeded small intestinal submucosa" 10 : 181-187, 2004

28 Roth CC, "Bladder regeneration in a canine model using hyaluronic acid-poly(lactic-co-glycolic-acid)nanoparticle modified porcine small intestinal submucosa" 108 : 148-155, 2011

29 Chen W, "Bladder regeneration by collagen scaffolds with collagen binding human basic fibroblast growth factor" 183 : 2432-2439, 2010

30 Kanematsu A, "Bladder regeneration by bladder acellular matrix combined with sustained release of exogenous growth factor" 170 : 1633-1638, 2003

31 Gomelsky A, "Bladder dysfunction in the adult : the basis for clinical management" Springer 265-276, 2014